SECOND AMENDMENT TO LEASELease • July 31st, 2019 • Apellis Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
This SECOND AMENDMENT TO LEASE (this “Amendment”) is entered into this 5th day of June, 2019 (the “Effective Date”) by and between NWALP PHOP Property Owner LLC, a Delaware limited liability company (the “Landlord”), and Apellis Pharmaceuticals, Inc., a Delaware corporation (the “Tenant”).
AMENDMENT TO DEVELOPMENT FUNDING AGREEMENTDevelopment Funding Agreement • July 31st, 2019 • Apellis Pharmaceuticals, Inc. • Pharmaceutical preparations
This Amendment to Development Funding Agreement (“Amendment”), made effective as of June 7, 2019 (the “Amendment Date”), entered into by and between Apellis Pharmaceuticals Inc., a Delaware corporation, with a principal place of business at 6400 Westwind Way, Suite A, Crestwood, KY 40014, USA (“Apellis”), and SFJ Pharmaceuticals XI, L.P. (“SFJ”), an SFJ Pharmaceuticals® company and limited partnership organized and existing under the laws of Delaware, having its principal place of business at 5000 Hopyard Road, Suite 330, Pleasanton, CA 94588, USA, amends that certain Development Funding Agreement dated as of February 28, 2019 (the “Agreement”), by and between Apellis and SFJ.
